View:
==============================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------------
FORM 8-A/A AMENDMENT NO. 3
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
--------------------------
XEROX CORPORATION
(Exact Name of Registrant as specified in its Charter)
New York 16-0468020
(State of incorporation or organization) (I.R.S. Employer
Identification No.)
P.O. Box 1600, 800 Long Ridge Road, Stamford, Connecticut 06904-1600
(Address of principal executive offices) (zip code)
If this Form relates to the registration of a class of debt securities
and is effective upon filing pursuant to General Instruction A(c)(1)
please check the following box. / /
If this Form relates to the registration of a class of debt securities
and is to become effective simultaneously with the effectiveness of a
concurrent registration statement under the Securities Act of 1933
pursuant to General Instruction A(c)(2) please check the following box. / /
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
- -------------------- ------------------------------
Common Stock, New York Stock Exchange
par value $1.00 per share Chicago Stock Exchange
Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
Item 1. Description of Securities to be Registered.
Item 1 of (i) the Registration Statement on Form 8-A filed with the
Securities and Exchange Commission (the "Commission") on April 6, 1987, as
amended by Amendment No. 1 thereto on Form 8 filed with the Commission on
February 6, 1989, as amended and restated by Amendment No. 2 thereto on Form
8-A filed with the Commission on June 4, 1996, and (ii) the Registration
Statement on Form 8-A filed with the Commission on February 23, 1990, as
amended by Amendment No. 1 thereto on Form 8 filed with the Commission on
March 8, 1990, as amended and restated by Amendment No. 2 thereto on Form 8-A
filed with the Commission on June 4, 1996, is hereby further amended and
restated in its entirety as follows:
DESCRIPTION OF COMMON STOCK
Certain statements under this heading are summaries of the provisions
with respect to common stock, par value $1.00 per share (the "Common Stock"),
of Xerox Corporation (the "Company") contained in the Company's Restated
Certificate of Incorporation. Such summaries do not purport to be complete
and are qualified in their entirety by reference to the Company's Restated
Certificate of Incorporation, which is incorporated herein by reference.
Authorized shares, issued and outstanding shares, and reserved shares
- ---------------------------------------------------------------------
The Company has the authority to issue 1,050,000,000 shares of Common
Stock. As of March 31, 1997, there were 325,902,324 shares of Common Stock
issued, of which 323,661,155 shares were then outstanding. Also as of such
date, there were 724,097,676 authorized but unissued shares of Common Stock,
of which 55,500,507 shares were held in reserve for issuance in connection
with (i) conversion of notes due in 2014, (ii) various executive incentive
plans of the Company, (iii) employees' stock option and similar plans, (iv)
exchange of non-voting exchangeable Class B Shares of Xerox Canada
Inc., a majority-owned subsidiary of the Company ("XCI"), and exercise of
rights granted under XCI's Executive Rights Plan and (v) conversion of the
Series B Convertible Preferred Stock held by the Trustee for the Company's
Employee Stock Ownership Plan (the "Series B Convertible Preferred Stock").
Dividend rights and restrictions
- --------------------------------
The holders of Common Stock are entitled to dividends as and when
declared by the Board of Directors out of the net assets of the Company
legally available therefor and there are no restrictions on the purchase or
redemption of such stock by the Company under its charter or by-laws or any
instrument to which it is a party, provided all dividends for past periods and
the dividends for the current quarter on any outstanding cumulative preferred
stock and retirement, purchase or sinking fund requirements thereon, if any,
have been paid or provided for, and subject further to the restrictions
referred to below.
Voting rights and noncumulative voting
- --------------------------------------
The holders of Common Stock possess voting rights for all purposes equal
with Series B Convertible Preferred Stock, one vote per share, subject,
however, to the right of the holders of any outstanding Cumulative Preferred
Stock of the Company, including the Series B Convertible Preferred Stock, if
six quarterly dividends thereon are in default, to elect, voting as a class,
two members of the Board of Directors of the Company, which right continues
until such default is cured. Certain mergers and consolidations, sales,
leases and pledges of assets are restricted by the provisions relating to
several of the Company's debt securities and credit agreements to which the
Company is a party. In addition, the separate vote or consent of the holders
of any outstanding Cumulative Preferred Stock of the Company, including the
Series B Convertible Preferred Stock, may be required to authorize certain
corporate action. Since the Common Stock does not have cumulative voting
rights, if they choose to do so, the holders of more than 50% of the Common
Stock and Series B Convertible Preferred Stock can elect all of the Directors
and the holders of the remaining shares cannot elect any Directors.
Liquidation rights
- ------------------
Upon the dissolution, liquidation or winding up of the Company, after the
payment in full of all preferential amounts to which the holders of
outstanding shares of all classes of stock having prior rights shall be
entitled, the remainder of the assets available for distribution to
shareholders will be distributed ratably among the holders of shares of Common
Stock.
Preemptive rights
- -----------------
Holders of Common Stock do not possess preemptive rights as to any class
of the Company's stock or as to any other securities of the Company.
Liability to further calls or assessments
- -----------------------------------------
The outstanding Common Stock is fully paid and nonassessable.
Shareholder Rights Plan
- -----------------------
On April 7, 1997, the Board of Directors of the Company approved a Rights
Agreement (the "Rights Agreement") between the Company and The First National
Bank of Boston, as Rights Agent (the "Rights Agent") and declared a dividend
distribution of one Right for each outstanding share of Common Stock to
shareholders of record at the close of business on April 16, 1997 (the "Record
Date"). The Rights replace the cumulative preferred stock purchase rights
(the "Old Rights") issued pursuant to a Rights Agreement dated as of April 6,
1987, as amended and restated as of February 6, 1989, between the Company and
The Chase Manhattan Bank, N.A. (as successor to Chase Lincoln First Bank,
N.A.), as Rights Agent (the "Old Rights Agreement"). The Old Rights Agreement
and the Old Rights are scheduled to expire at the close of business on April
16, 1997 pursuant to the terms thereof.
Until the Distribution Date (or earlier redemption or expiration of the
Rights), which is defined below, the Rights will not be exercisable, will not
have any voting rights and will trade with the Common Stock. "Distribution
Date" shall mean the earlier to occur of (i) 10 business days following the
date of a public announcement that a person, together with persons affiliated
or associated with it, has acquired beneficial ownership of 20% or more of the
outstanding Common Stock or (ii) 10 business days following the earlier of the
commencement of, or the first public announcement of the intent to commence, a
tender offer or exchange offer by a person other than the Company if, upon
consummation of the offer, such person, together with persons affiliated or
associated with it, would be the beneficial owner of 20% or more of the
outstanding Common Stock. As soon as practicable following the Distribution
Date, separate certificates evidencing the Rights ("Rights Certificates") will
be mailed to holders of record of the Common Stock as of the close of business
on the Distribution Date; provided that the Company is required to make the
necessary and appropriate rounding adjustments so that Rights Certificates
representing only whole numbers of Rights are distributed, and cash is paid in
lieu of any fractional Rights. From and after the Distribution Date, such
separate Rights Certificates alone will evidence the Rights. Except as
otherwise determined by the Board of Directors, and except in connection with
the exercise of employee stock options, any other issuance of Common Stock
with respect to awards outstanding under employee benefit plans outstanding on
the Distribution Date and in connection with the conversion of convertible
securities issued after April 7, 1997, only Common Stock issued prior to the
Distribution Date will be issued with Rights.
Each Right entitles the registered holder to purchase from the Company
one three-hundredth of a share of a series of cumulative preferred stock of
the Company designated Series A Cumulative Preferred Stock (the "Preferred
Stock"), at a price of $250.00 (the "Purchase Price"), subject to adjustment.
If an Acquiring Person (as defined below) acquires the Company in a
transaction in which the Company and its Common Stock survive, the Rights
(other than the Rights beneficially owned by the Acquiring Person or by
certain related parties and transferees) will entitle the holder thereof, upon
payment of the then current Purchase Price, to purchase Common Stock (or, in
certain circumstances as determined by the Company, other securities, cash, or
other property) having a value of two times the Purchase Price. If certain
types of mergers, sales of assets or other business combinations involving the
Company occur after the Rights become exercisable, the Rights (other than the
Rights beneficially owned by the Acquiring Person or by certain related
parties and transferees) will entitle the holder thereof, upon payment of the
then current Purchase Price, to purchase common stock of the acquiring company
having a value of two times the Purchase Price. Notwithstanding the
foregoing, at any time after the acquisition by a person or group of
affiliated or associated persons of beneficial ownership of 20% or more of the
outstanding shares of Common Stock and prior to the acquisition by such person
or group of 50% or more of the outstanding shares of Common Stock, the Board
of Directors may exchange the Rights (other than Rights owned by such person
or group which have become void), in whole or in part, at an exchange ratio of
one share of Common Stock, or one three-hundredth of a share of Preferred
Stock (or of a share of a class or series of the Company's preferred stock
having equivalent rights, preferences and privileges), per Right (subject to
adjustment). "Acquiring Person" shall mean any person who constitutes an
"Interested Shareholder" as defined in Section 912 of the New York Business
Corporation Law, in effect from time to time (generally defined to include any
person who or which, together with all persons affiliated or associated with
it, shall be the beneficial owner of 20% or more of the shares of Common Stock
then outstanding).
At any time until the close of business on the 10th business day
following the date of a public announcement that a person has become an
Acquiring Person, the Company may redeem all, but not less than all, the then
outstanding Rights at a redemption price of $.01 per Right. The foregoing
notwithstanding, the Rights generally may not be redeemed for 120 days
following a change in the majority of the Board of Directors of the Company as
a result of a proxy contest.
The Rights Agreement may be amended by the Board of Directors of the
Company prior to the Distribution Date. Thereafter, the Rights Agreement may
be amended by the Board of Directors of the Company in order to (i) cure any
ambiguity, (ii) shorten or lengthen any time period under the Rights
Agreement, or (iii) make changes that will not adversely affect the interests
of the holders of Rights; provided such lengthening is for the purpose of
protecting, enhancing or clarifying the rights of, and/or the benefits to, the
holders of Rights, and further; provided, that no amendment may be made at
such time as the Rights are not redeemable. The Rights will expire at the
close of business on April 16, 2007, unless earlier redeemed or exchanged by
the Company.
A copy of the Rights Agreement has been filed with the Commission as an
Exhibit to a Current Report on Form 8-K dated April 7, 1997. A copy of the
Rights Agreement will be available free of charge from the Company. The
foregoing summary description of the Rights does not purport to be complete
and is qualified in its entirety by reference to the Rights Agreement, which
is incorporated herein by reference.
The Rights have certain anti-takeover effects. The Rights will cause
substantial dilution to a person or group that attempts to acquire the Company
without conditioning the offer on a substantial number of Rights being
acquired. In general, the Rights should not interfere with any merger or
other business combination approved by the Board of Directors of the Company
since the Board of Directors generally may, at its option, redeem at any time
until the close of business on the Stock Acquisition Date, all, but not less
than all, the then outstanding Rights at the Redemption Price.
Item 2. Exhibits.
Exhibit No. Description
- ----------- ------------
(1) Restated Certificate of Incorporation of the Company filed by the
Department of State of New York on October 29, 1996 (incorporated
by reference to Exhibit 3(a)(1) to the Company's Quarterly Report
on Form 10-Q for the Quarter Ended September 30, 1996).
(2) By-Laws of the Company, as amended through May 29, 1991
(incorporated by reference to Exhibit 3(b)(2) to the Company's
Quarterly Report on Form 10-Q for the Quarter Ended June 30,
1991).
(3) Form of Rights Agreement dated as of April 7, 1997, between
the Company and The First National Bank of Boston, as Rights
Agent, which includes as Exhibits A and B thereto the Form of
Rights Certificate and the Summary of Rights to Purchase
Preferred Stock, respectively (incorporated by reference to
Exhibit 4.10 to the Company's Current Report on Form 8-K dated
April 7, 1997).
(4) Press Release dated April 7, 1997 (incorporated by reference to
Exhibit 4 to the Company's Registration Statement on Form 8-A
dated April 7, 1997).
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to
be signed on its behalf by the undersigned, thereunto duly authorized.
XEROX CORPORATION (Registrant)
By: /s/ Martin S. Wagner
--------------------------
Name: Martin S. Wagner
Title: Assistant Secretary
Date: April 7, 1997
EXHIBIT INDEX
Exhibit No. Description
- ----------- ------------
(1) Restated Certificate of Incorporation of the Company filed by the
Department of State of New York on October 29, 1996 (incorporated
by reference to Exhibit 3(a)(1) to the Company's Quarterly Report
on Form 10-Q for the Quarter Ended September 30, 1996).
(2) By-Laws of the Company, as amended through May 29, 1991
(incorporated by reference to Exhibit 3(b)(2) to the Company's
Quarterly Report on Form 10-Q for the Quarter Ended June 30,
1991).
(3) Form of Rights Agreement dated as of April 7, 1997, between
the Company and The First National Bank of Boston, as Rights
Agent, which includes as Exhibits A and B thereto the Form of
Rights Certificate and the Summary of Rights to Purchase
Preferred Stock, respectively (incorporated by reference to
Exhibit 4.10 to the Company's Current Report on Form 8-K dated
April 7, 1997).
(4) Press Release dated April 7, 1997 (incorporated by reference to
Exhibit 4 to the Company's Registration Statement on Form 8-A
dated April 7, 1997).